Stage 2 · Toolkit 2.6
Reproductive & Developmental Toxicology Program
Plan reproductive and developmental toxicology work where relevant to population, indication, and stage.
What it helps control
Operational support
Helps teams establish the procedures, working records, trackers, and evidence needed for Reproductive & Developmental Toxicology Program.
How it helps your team
Surface evidence gaps and dependencies before they delay IND, CTA, or first-in-human decisions.
Designed for
Nonclinical development, toxicology, safety pharmacology, bioanalysis, Regulatory Affairs, and Quality teams.
Included files
Know exactly what the toolkit contains
The file names below show what is included. File contents become available only after purchase.
Word documents
- Reproductive Toxicology Strategy Plan
- DART Study Planning Template
- Reproductive Toxicology Report Review Checklist
- Pregnancy Risk Evidence Summary
- Reproductive Toxicology Gap Assessment
- Reproductive Toxicology Decision Memo
Excel workbooks
- Reproductive Toxicology Study Tracker
- DART Findings Tracker
- Pregnancy Risk Matrix
- Reproductive Toxicology Evidence Matrix
- Source Data Reference Log
Related toolkits
Continue within stage 2
Nonclinical Development Plan & IND/CTA-Enabling Strategy
Define the nonclinical package needed to support IND, CTA, first-in-human, and clinical development.
2.2GLP Compliance & Sponsor Oversight
Ensure GLP studies are appropriately planned, overseen, monitored, documented, reported, and archived.
2.3Toxicology Study Planning & Management
Manage toxicology studies and interpret key findings for regulatory and FIH readiness.